Recombinant Influenza A H1N1 Neuraminidase / NA (N295S mutation) (Active)
-
Catalog number
RP-022A
-
Price
Please ask
-
Size
100U
-
-
Protein category
Recombinant protein
-
Source
Human Cells
-
Target
A H1N1 Neuraminidase / NA (NDa A H1N1 Neuraminidase / NA (N295S mutation)
-
-
Description
Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.
-
Additional source
Recombinants or rec. proteins
-
Group
recombinants
-
Gene target
-
Short name
Recombinant Influenza A H1N1 Neuraminidase / NA (N295S mutation) (Active)
-
Technique
Recombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. adv advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
Label
Unlabeled
-
Species
H1N1, Influenza
-
Alternative name
Rec. Influenza A H1N1 Neuraminidase / NA (N295S mutation) (functionnal)
-
Alternative technique
rec
-
Virus
influenza
-
MeSH Data
-
Name
-
Concept
Scope note:
The initial culturing of cells derived directly from fresh TISSUES.
-
Tree numbers
- E01.370.225.500.223.500
- E05.200.500.265.500
- E05.242.223.500
- E05.481.500.249.500
-
Qualifiers
ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data
Similar products